Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Follow Up On CD8-Depleted Donor-Lymphocyte Infusions After T-Cell Depleted Allogeneic Hemopoietic Stem Cell Transplantation

Eva Maria Wagner, MD, Daniela Wehler, MD, Timo Schmitt, MD, Aline N. Lay, Karin Kolbe, MD, Matthias Theobald, MD, PhD, Wolfgang Herr, MD, Ralf G Meyer, MD

Blood (2013) 122 (21): 4526.

https://doi.org/10.1182/blood.V122.21.4526.4526

Published: 2013

Journal Articles

Impact of Prophylactic CD8-Depleted Donor-Lymphocyte Infusions After Allogeneic Hematopoietic Stem Cell Transplantation and Alemtuzumab Mediated T-Cell Depletion,

Eva M Wagner, MD, Daniela Wehler, MD, Karin Kolbe, MD, Matthias Theobald, MD, PhD, Wolfgang Herr, MD, Ralf G Meyer, MD

Blood (2011) 118 (21): 4109.

https://doi.org/10.1182/blood.V118.21.4109.4109

Published: 2011

Journal Articles

Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti–T-cell globulin ATG-Fresenius

Blood (2011) 117 (23): 6375–6382.

https://doi.org/10.1182/blood-2011-01-329821

Published: 2011

Includes: Supplemental data

Journal Articles

Treosulfan, Etoposide and Cyclophosphamide as Non TBI-Conditioning Regimen Followed by Allogeneic SCT for Acute Lymphoblastic Leukemia

Nicolaus Kröger, Matthias Stelljes, Martin Bornhäuser, Wolfgang A. Bethge, Renate Arnold, Hans Martin, Christoph Schmid, M.D., Karin Kolbe, Nicola Goekbuget, MD, Dieter Hoelzer, MD, Axel R. Zander, MD, Dietrich Beelen

Blood (2010) 116 (21): 1327.

https://doi.org/10.1182/blood.V116.21.1327.1327

Published: 2010

Journal Articles

Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia with Normal Karyotype: A Risk Factor Analysis in 247 Patients, Based On Molecular Markers and Stage at Transplantation.

Blood (2009) 114 (22): 1209.

https://doi.org/10.1182/blood.V114.22.1209.1209

Published: 2009

Journal Articles

Allogeneic Stem Cell Transplantation for Acquired Aplastic Anemia: Better Outcome with Bone Marrow as Compared to Peripheral Blood in HLA-Matched Sibling Donor Transplantation and Improved Outcome Over Time After Matched Unrelated Donor Transplantation. A Retrospective Analysis of Transplants Reported to the German Registry for Stem Cell Transplantation (DRST).

Hubert Schrezenmeier, Ulrike Feldmann, Hellmut Ottinger, Matthias Eder, Monika Führer, Hans-Jochem Kolb, Axel Zander, Karin Kolbe, Dietger Niederwieser, Donald W. Bunjes, MD, PhD, Rainer Schwerdtfeger, MD, Rupert Handgretinger, Karl Welte, Carlheinz Müller, Gerhard Ehninger, Jürgen Finke, Dietrich Beelen

Blood (2009) 114 (22): 876.

https://doi.org/10.1182/blood.V114.22.876.876

Published: 2009

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation (autoHSCT) in CLL: First Results of An EBMT Randomized Trial Comparing Autotransplant Versus Wait and Watch.

Mauricette Michallet, MD, PhD, Peter Dreger, MD, PhD, Laurent Sutton, MD, Ronald Brand, Sue Richards, Anja van Biezen, Mohamad Sobh, Pharm.M, Alois Gratwohl, MD, Karin Kolbe, MD, Claire E. Dearden, MD, Michael Hallek, T. M. de Witte, MD, PhD, Dietger W. Niederwieser, MD, Michel Leporrier, MD, Donald Milligan, MD

Blood (2009) 114 (22): 877.

https://doi.org/10.1182/blood.V114.22.877.877

Published: 2009

Journal Articles

Prior Treatment with Alemtuzumab Interferes with T-Cell Engraftment After Allogeneic Stem Cell Transplantation in Patients with Chronic Lymphocytic Leukemia.

Johannes Schetelig, Christian Thiede, Alexander Kiani, Uwe Platzbecker, Uta Oelschlaegel, Matthias Haenel, Gaby Geissler, Rainer Schwerdtfeger, MD, Karin Kolbe, MD, Martin Kaufmann, Matthias Zeis, MD, Kerstin Schaefer-Eckart, MD, Wolfgang Siegert, MD, PhD, Gerhard Ehninger

Blood (2009) 114 (22): 3351.

https://doi.org/10.1182/blood.V114.22.3351.3351

Published: 2009

Journal Articles

Relevance of the Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) On Non-Relapse Related Mortality (NRM) in Patients with Acute Lymphoblastic Leukemia (ALL) Receiving Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in First Complete Remission: Results From the GMALL Study Group.

Matthias Stelljes, MD, Mareike David, Renate Arnold, MD, Dietrich W Beelen, MD, Wolfgang A Bethge, MD, Martin Bornhäuser, MD, Jolanta Dengler, MD, Juergen Finke, MD, Hans J Kolb, MD, Karin Kolbe, MD, Nicolaus Kröger, MD, Dietger Niederwieser, MD, Wolf Rösler, MD, Rainer Schwerdtfeger, MD, Joachim Kienast, MD, Nicola Goekbuget, MD, Dieter Hoelzer, MD, PhD

Blood (2009) 114 (22): 3352.

https://doi.org/10.1182/blood.V114.22.3352.3352

Published: 2009

Journal Articles

A Randomized Prospective Multicenter Phase III Trial Comparing Standard GvHD Prophylaxis with Cyclosporine and Methotrexate with Additional Pretransplant ATG Fresenius (ATG-F) in Allogeneic Stem Cell Transplantation from Matched Unrelated Donors

Blood (2008) 112 (11): 57.

https://doi.org/10.1182/blood.V112.11.57.57

Published: 2008

Journal Articles

CD8-Depleted Donor Lymphocyte Infusions Convert Mixed into Complete Donor T-Cell Chimerism after T-Cell Depleted Allogeneic Stem Cell Transplantation.

Ralf G Meyer, MD, Eva M Wagner, MD, Timo Schmitt, Klaus Bender, PhD, Udo F Hartwig, PhD, Christoph Huber, MD, Karin Kolbe, MD, Wolfgang Herr, MD

Blood (2008) 112 (11): 2160.

https://doi.org/10.1182/blood.V112.11.2160.2160

Published: 2008

Journal Articles

Improved Outcome for Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) with Poor Risk Cytogenetics – Result from An Analysis on 172 Patients Receiving FLAMSA-RIC Conditioning for Allogeneic Stem Cell Transplantatioin (SCT).

Blood (2008) 112 (11): 1971.

https://doi.org/10.1182/blood.V112.11.1971.1971

Published: 2008

Journal Articles

Related Versus Unrelated Donor Transplantation for High Risk (HiRi) Acute Myeloid Leukemia (AML) in First Complete Remission (CR1).

Joachim Kienast, Hans-Jochem Kolb, Dietrich W. Beelen, Maria Cristina Sauerland, Björna Berning, Albrecht Reichle, Ernst Holler, Renate Arnold, Karin Kolbe, Peter Staib, Rainer Schwerdtfeger, Matthias Stelljes, Christoph Schmid, Claudia Haferlach, Wolfgang E. Berdel, Wolfgang Hiddemann, Thomas Buchner

Blood (2007) 110 (11): 169.

https://doi.org/10.1182/blood.V110.11.169.169

Published: 2007

Journal Articles

Graft-Versus-Host Disease or Infection: Rapid Detection of HLA Mismatch-Reactive T Cells Ex Vivo Can Facilitate Diagnosis and Guide Therapy after Allogeneic Transplantation.

Eva Distler, Simone Thomas, Elke Schuerer, Cedrik Britten, Martin Schuler, Christoph Huber, Karin Kolbe, Thomas Woelfel, Ralf Meyer, Wolfgang Herr

Blood (2007) 110 (11): 4993.

https://doi.org/10.1182/blood.V110.11.4993.4993

Published: 2007

Journal Articles

Chimerism Analysis of Langerhans Cells Early after T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation.

Timo Schmitt, Kerstin Schneiker, Abdo Konur, PhD, Ali Hadian, MD, Klaus Bender, PhD, Esther von Stebut, MD, Karin Kolbe, MD, Christoph Huber, MD, Wolfgang Herr, MD, Ralf G. Meyer, MD

Blood (2007) 110 (11): 3249.

https://doi.org/10.1182/blood.V110.11.3249.3249

Published: 2007

Journal Articles

Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell–depleted reduced-intensity transplantation

Ralf G. Meyer, Cedrik M. Britten, Daniela Wehler, Klaus Bender, Georg Hess, Abdo Konur, Udo F. Hartwig, Thomas C. Wehler, Andrew J. Ullmann, Chiara Gentilini, Lutz Uharek, Christoph Huber, Karin Kolbe, Wolfgang Herr

Blood (2006) 109 (1): 374–382.

https://doi.org/10.1182/blood-2006-03-005769

Published: 2006

Journal Articles

Preemptive Transfer of GMP-Grade CD8-Depleted Donor Lymphocytes after T-Cell Depleted Reduced-Intensity Transplantation.

Ralf G. Meyer, MD, Cedrik M. Britten, MD, Abdo Konur, PhD, Klaus Bender, PhD, Daniela Wehler, MD, Udo Hartwig, PhD, Thomas C. Wehler, MD, Chiara Gentilini, MD, Lutz Uharek, MD, Christoph Huber, MD, Karin Kolbe, MD, Wolfgang Herr, MD

Blood (2005) 106 (11): 297.

https://doi.org/10.1182/blood.V106.11.297.297

Published: 2005

Journal Articles

Campath-1H-Based Reduced-Intensity Conditioning Followed by Allogeneic Blood Stem-Cell Transplantation and Preemptive CD8-Depleted Donor Lymphocyte Infusions.

Ralf G. Meyer, MD, Daniela Wehler, MD, Thomas C. Wehler, MD, Cedrik M. Britten, MD, Alexander Burchardt, MD, Udo Hartwig, PhD, Christoph Huber, MD, Karin Kolbe, MD, Wolfgang Herr, MD

Blood (2004) 104 (11): 5069.

https://doi.org/10.1182/blood.V104.11.5069.5069

Published: 2004

NARROW

Follow Up On CD8-Depleted Donor-Lymphocyte Infusions After T-Cell Depleted Allogeneic Hemopoietic Stem Cell Transplantation

Impact of Prophylactic CD8-Depleted Donor-Lymphocyte Infusions After Allogeneic Hematopoietic Stem Cell Transplantation and Alemtuzumab Mediated T-Cell Depletion,

Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti–T-cell globulin ATG-Fresenius

Treosulfan, Etoposide and Cyclophosphamide as Non TBI-Conditioning Regimen Followed by Allogeneic SCT for Acute Lymphoblastic Leukemia

Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia with Normal Karyotype: A Risk Factor Analysis in 247 Patients, Based On Molecular Markers and Stage at Transplantation.

Autologous Hematopoietic Stem Cell Transplantation (autoHSCT) in CLL: First Results of An EBMT Randomized Trial Comparing Autotransplant Versus Wait and Watch.

Prior Treatment with Alemtuzumab Interferes with T-Cell Engraftment After Allogeneic Stem Cell Transplantation in Patients with Chronic Lymphocytic Leukemia.

A Randomized Prospective Multicenter Phase III Trial Comparing Standard GvHD Prophylaxis with Cyclosporine and Methotrexate with Additional Pretransplant ATG Fresenius (ATG-F) in Allogeneic Stem Cell Transplantation from Matched Unrelated Donors

CD8-Depleted Donor Lymphocyte Infusions Convert Mixed into Complete Donor T-Cell Chimerism after T-Cell Depleted Allogeneic Stem Cell Transplantation.

Improved Outcome for Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) with Poor Risk Cytogenetics – Result from An Analysis on 172 Patients Receiving FLAMSA-RIC Conditioning for Allogeneic Stem Cell Transplantatioin (SCT).

Related Versus Unrelated Donor Transplantation for High Risk (HiRi) Acute Myeloid Leukemia (AML) in First Complete Remission (CR1).

Graft-Versus-Host Disease or Infection: Rapid Detection of HLA Mismatch-Reactive T Cells Ex Vivo Can Facilitate Diagnosis and Guide Therapy after Allogeneic Transplantation.

Chimerism Analysis of Langerhans Cells Early after T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation.

Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell–depleted reduced-intensity transplantation

Preemptive Transfer of GMP-Grade CD8-Depleted Donor Lymphocytes after T-Cell Depleted Reduced-Intensity Transplantation.

Campath-1H-Based Reduced-Intensity Conditioning Followed by Allogeneic Blood Stem-Cell Transplantation and Preemptive CD8-Depleted Donor Lymphocyte Infusions.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only